| Physiotherapy and Rehabilitation (English) | |||||
| Bachelor | TR-NQF-HE: Level 6 | QF-EHEA: First Cycle | EQF-LLL: Level 6 | ||
| Course Code: | PRE209 | ||||
| Course Name: | Pharmachology in PT | ||||
| Semester: | Spring | ||||
| Course Credits: |
|
||||
| Language of instruction: | English | ||||
| Course Condition: | |||||
| Does the Course Require Work Experience?: | No | ||||
| Type of course: | Compulsory Courses | ||||
| Course Level: |
|
||||
| Mode of Delivery: | Face to face | ||||
| Course Coordinator: | Prof. Dr. MEHMET FERİT İSBİR | ||||
| Course Lecturer(s): | Asst. Prof. Oğuzhan Aydemir | ||||
| Course Assistants: |
| Course Objectives: | The aim of this course is to give information about basic principles of pharmacology, drugs used to affect the autonomic systems, drugs used in dısorders of the central nervous system, drugs used in the treatment of respiratory system diseases, drugs that act in the gastrointestinal system, endocrine pharmacology, infections and drug treatments, pain, nonsteroidal anti-inflammatory drugs, nonopioid analgesics, opioid analgesics, drugs used in musculoskeletal disorders, muscle relaxants, antirheumatic drugs, nutritional supplements and vitamins, abuse of drugs in sport. |
| Course Content: | General Principles of Pharmacology Autonomic drugs Drugs that act in the central nervous system Cardiovascular-renal drugs Drugs used in the treatment of respiratory system diseases Drugs that act in the gastrointestinal system Endocrine pharmacology Abuse of drugs in sport. Infections and drug treatments Pain, Nonsteroidal Anti-inflammatory drugs Nonopioid analgesics, opioid analgesics Drugs used in musculoskeletal disorders, muscle relaxants Antirheumatic drugs Nutritional supplements and vitamins |
|
The students who have succeeded in this course;
1) will be able to define the general terms/principles of pharmacology 2) will have the understanding of autonomic drugs, can define and give examples of mechanism of action, their pharmacodynamics/pharmacokinetics, advers effects and drug interactions 3) will have the understanding of drugs that act in the central nervous system and can define and give examples of mechanism of action, their pharmacodynamics/pharmacokinetics, advers effects, and drug interactions. 4) will have the understanding of cardiovascular-renal drugs and can define and give examples of mechanism of action, their pharmacodynamics/pharmacokinetics, advers effects, and drug interactions. 5) will have the understanding of drugs used in the respiratory system diseases and can define and give examples of mechanism of action, their pharmacodynamics/pharmacokinetics, advers effects, and drug interactions. 5) will have the understanding of drugs used in the infections and can define and give examples of mechanism of action, their pharmacodynamics/pharmacokinetics, advers effects, and drug interactions. 6) will have the understanding of drugs that act gastrointestinal system and can define and give examples of mechanism of action, their pharmacodynamics/pharmacokinetics, advers effects, and drug interactions. 7) will have the understanding of drugs that act endocrine and can define and give examples of mechanism of action, their pharmacodynamics/pharmacokinetics, advers effects, and drug interactions. 8) will have the understanding of drugs used in the pain and can define and give examples of mechanism of action, their pharmacodynamics/pharmacokinetics, advers effects, and drug interactions. 9) will have the understanding of drugs used in musculoskeletal disorders, and can define and give examples of mechanism of action, their pharmacodynamics/pharmacokinetics, advers effects, and drug interactions. 10) will have the understanding of antirheumatic drugs and can define and give examples of mechanism of action, their pharmacodynamics/pharmacokinetics, advers effects, and drug interactions 11) will have the understanding of nutritional supplements vitamins and can define and give examples of mechanism of action, their pharmacodynamics/pharmacokinetics, advers effects, and drug interactions 12) will have the understanding of drugs used in sports and can define and give examples of mechanism of action, their pharmacodynamics/pharmacokinetics, advers effects, and drug interactions |
| Week | Subject | Related Preparation |
| 1) | General Principles of Pharmacology | Raffa R.B., Rawls, S.M., Portyansky Beyzarov, E. (2014) Netter’s Illustrated Pharmacology, Elsevier Saunders. Whalen, K., Finkel,R.(coll.ed.), Panavelil T.A..(coll.ed.) Harvey R.A. (series ed) (2015) Lippincott Illustrated Reviews (6th ed), Wolters Kluwer Katzung,B.G.,(2018) Basic and Clinical Pharmacology (14th ed.), McGraw-Hill Education, Lange. |
| 2) | Autonomic drugs | Raffa R.B., Rawls, S.M., Portyansky Beyzarov, E. (2014) Netter’s Illustrated Pharmacology, Elsevier Saunders. Whalen, K., Finkel,R.(coll.ed.), Panavelil T.A..(coll.ed.) Harvey R.A. (series ed) (2015) Lippincott Illustrated Reviews (6th ed), Wolters Kluwer Katzung,B.G.,(2018) Basic and Clinical Pharmacology (14th ed.), McGraw-Hill Education, Lange. |
| 3) | Drugs that act in the central nervous system | Raffa R.B., Rawls, S.M., Portyansky Beyzarov, E. (2014) Netter’s Illustrated Pharmacology, Elsevier Saunders. Whalen, K., Finkel,R.(coll.ed.), Panavelil T.A..(coll.ed.) Harvey R.A. (series ed) (2015) Lippincott Illustrated Reviews (6th ed), Wolters Kluwer Katzung,B.G.,(2018) Basic and Clinical Pharmacology (14th ed.), McGraw-Hill Education, Lange. |
| 4) | Cardiovascular-renal drugs | Raffa R.B., Rawls, S.M., Portyansky Beyzarov, E. (2014) Netter’s Illustrated Pharmacology, Elsevier Saunders. Whalen, K., Finkel,R.(coll.ed.), Panavelil T.A..(coll.ed.) Harvey R.A. (series ed) (2015) Lippincott Illustrated Reviews (6th ed), Wolters Kluwer Katzung,B.G.,(2018) Basic and Clinical Pharmacology (14th ed.), McGraw-Hill Education, Lange. |
| 5) | Drugs used in the treatment of respiratory system diseases | Raffa R.B., Rawls, S.M., Portyansky Beyzarov, E. (2014) Netter’s Illustrated Pharmacology, Elsevier Saunders. Whalen, K., Finkel,R.(coll.ed.), Panavelil T.A..(coll.ed.) Harvey R.A. (series ed) (2015) Lippincott Illustrated Reviews (6th ed), Wolters Kluwer Katzung,B.G.,(2018) Basic and Clinical Pharmacology (14th ed.), McGraw-Hill Education, Lange. |
| 6) | Drugs that act in the gastrointestinal system | Raffa R.B., Rawls, S.M., Portyansky Beyzarov, E. (2014) Netter’s Illustrated Pharmacology, Elsevier Saunders. Whalen, K., Finkel,R.(coll.ed.), Panavelil T.A..(coll.ed.) Harvey R.A. (series ed) (2015) Lippincott Illustrated Reviews (6th ed), Wolters Kluwer Katzung,B.G.,(2018) Basic and Clinical Pharmacology (14th ed.), McGraw-Hill Education, Lange. |
| 7) | Endocrine pharmacology (Midterm Exam) | Raffa R.B., Rawls, S.M., Portyansky Beyzarov, E. (2014) Netter’s Illustrated Pharmacology, Elsevier Saunders. Whalen, K., Finkel,R.(coll.ed.), Panavelil T.A..(coll.ed.) Harvey R.A. (series ed) (2015) Lippincott Illustrated Reviews (6th ed), Wolters Kluwer Katzung,B.G.,(2018) Basic and Clinical Pharmacology (14th ed.), McGraw-Hill Education, Lange. |
| 8) | Infections and drug treatments | Raffa R.B., Rawls, S.M., Portyansky Beyzarov, E. (2014) Netter’s Illustrated Pharmacology, Elsevier Saunders. Whalen, K., Finkel,R.(coll.ed.), Panavelil T.A..(coll.ed.) Harvey R.A. (series ed) (2015) Lippincott Illustrated Reviews (6th ed), Wolters Kluwer Katzung,B.G.,(2018) Basic and Clinical Pharmacology (14th ed.), McGraw-Hill Education, Lange. |
| 9) | Pain, Nonsteroidal Anti-inflammatory drugs | Raffa R.B., Rawls, S.M., Portyansky Beyzarov, E. (2014) Netter’s Illustrated Pharmacology, Elsevier Saunders. Whalen, K., Finkel,R.(coll.ed.), Panavelil T.A..(coll.ed.) Harvey R.A. (series ed) (2015) Lippincott Illustrated Reviews (6th ed), Wolters Kluwer Katzung,B.G.,(2018) Basic and Clinical Pharmacology (14th ed.), McGraw-Hill Education, Lange. |
| 10) | Nonopioid analgesics, opioid analgesics | Raffa R.B., Rawls, S.M., Portyansky Beyzarov, E. (2014) Netter’s Illustrated Pharmacology, Elsevier Saunders. Whalen, K., Finkel,R.(coll.ed.), Panavelil T.A..(coll.ed.) Harvey R.A. (series ed) (2015) Lippincott Illustrated Reviews (6th ed), Wolters Kluwer Katzung,B.G.,(2018) Basic and Clinical Pharmacology (14th ed.), McGraw-Hill Education, Lange. |
| 11) | Drugs used in musculoskeletal disorders, muscle relaxants | Raffa R.B., Rawls, S.M., Portyansky Beyzarov, E. (2014) Netter’s Illustrated Pharmacology, Elsevier Saunders. Whalen, K., Finkel,R.(coll.ed.), Panavelil T.A..(coll.ed.) Harvey R.A. (series ed) (2015) Lippincott Illustrated Reviews (6th ed), Wolters Kluwer Katzung,B.G.,(2018) Basic and Clinical Pharmacology (14th ed.), McGraw-Hill Education, Lange. |
| 12) | Antirheumatic drugs | Raffa R.B., Rawls, S.M., Portyansky Beyzarov, E. (2014) Netter’s Illustrated Pharmacology, Elsevier Saunders. Whalen, K., Finkel,R.(coll.ed.), Panavelil T.A..(coll.ed.) Harvey R.A. (series ed) (2015) Lippincott Illustrated Reviews (6th ed), Wolters Kluwer Katzung,B.G.,(2018) Basic and Clinical Pharmacology (14th ed.), McGraw-Hill Education, Lange. |
| 13) | Abuse of drugs used in sports | Raffa R.B., Rawls, S.M., Portyansky Beyzarov, E. (2014) Netter’s Illustrated Pharmacology, Elsevier Saunders. Whalen, K., Finkel,R.(coll.ed.), Panavelil T.A..(coll.ed.) Harvey R.A. (series ed) (2015) Lippincott Illustrated Reviews (6th ed), Wolters Kluwer Katzung,B.G.,(2018) Basic and Clinical Pharmacology (14th ed.), McGraw-Hill Education, Lange. |
| 14) | Nutritional supplements and vitamins | Raffa R.B., Rawls, S.M., Portyansky Beyzarov, E. (2014) Netter’s Illustrated Pharmacology, Elsevier Saunders. Whalen, K., Finkel,R.(coll.ed.), Panavelil T.A..(coll.ed.) Harvey R.A. (series ed) (2015) Lippincott Illustrated Reviews (6th ed), Wolters Kluwer Katzung,B.G.,(2018) Basic and Clinical Pharmacology (14th ed.), McGraw-Hill Education, Lange. |
| Course Notes / Textbooks: | Raffa R.B., Rawls, S.M., Portyansky Beyzarov, E. (2014) Netter’s Illustrated Pharmacology, Elsevier Saunders. Whalen, K., Finkel,R.(coll.ed.), Panavelil T.A..(coll.ed.) Harvey R.A. (series ed) (2015) Lippincott Illustrated Reviews (6th ed), Wolters Kluwer Katzung,B.G.,(2018) Basic and Clinical Pharmacology (14th ed.), McGraw-Hill Education, Lange. |
| References: | Raffa R.B., Rawls, S.M., Portyansky Beyzarov, E. (2014) Netter’s Illustrated Pharmacology, Elsevier Saunders. Whalen, K., Finkel,R.(coll.ed.), Panavelil T.A..(coll.ed.) Harvey R.A. (series ed) (2015) Lippincott Illustrated Reviews (6th ed), Wolters Kluwer Katzung,B.G.,(2018) Basic and Clinical Pharmacology (14th ed.), McGraw-Hill Education, Lange. |
| Course Learning Outcomes | 1 |
2 |
3 |
4 |
5 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Program Outcomes | |||||||||||||||
| 1) Physiotherapy defines the basic medical sciences concepts and principles related to physiotherapy and rehabilitation evaluation processes, basic elements and methodological application principles. | |||||||||||||||
| 2) He/She lists clinical evaluation tools and methods by analyzing the collected information about evaluation in physiotherapy according to reasoning and problem solving processes. | |||||||||||||||
| 3) Explain the indications, contraindications, side effects and intervention strategies of the physiotherapy approaches and the mechanisms used to cope with functional disability and possible intervention methods. Sorts the near and far term targets according to functional levels. | |||||||||||||||
| 4) It is based on the physiotherapy information related to the general health of the service area. It defines the health and lifestyle profile, deficiencies, body structure and function, activity-participation level of the person and determines the evaluation and treatment priorities in this direction. | |||||||||||||||
| 5) With the data obtained from physiotherapy assessments, it creates and implements an individual-oriented physiotherapy intervention plan in accordance with the diagnosis of physiotherapy by using information literacy, evidence-based clinical decision-making processes. | |||||||||||||||
| 6) It applies to the service area the exercise program planned as well as consultancy in the protection and development of health outside the disease states. | |||||||||||||||
| 7) Develops a scientific research proposal about physiotherapy and rehabilitation. | |||||||||||||||
| 8) He leads the clinical practice in accordance with the quality standards in the process of establishment and management of the institutions / organizations / centers providing physiotherapy and rehabilitation services. | |||||||||||||||
| 9) As a physical therapist, he works with his colleagues and professionals from different disciplines. | |||||||||||||||
| 10) Evaluates information sources with a critical approach by adapting to new conditions, learning new ideas, developing new ideas, and giving importance to quality. | |||||||||||||||
| 11) By using professional information sources and physiotherapy techniques effectively, it reaches information, adopts positive attitude and behavior model and determines learning objectives. | |||||||||||||||
| 12) Uses effective communication skills by respecting the confidentiality of service areas from a biopsychosocial point of view during physiotherapy evaluation and interventions. | |||||||||||||||
| 13) It adopts the ethical, deontological and legal framework for the collection, recording and reporting of necessary data during the physiotherapy evaluation and interventions. | |||||||||||||||
| 14) Observes the rights and responsibilities of the physicians in physiotherapy and rehabilitation practices and acts in accordance with the legislation and professional ethics rules in cooperation with the related disciplines. | |||||||||||||||
| 15) Physiotherapist takes responsibility with the understanding of interdisciplinary cooperation while preserving its identity, consciousness and professional autonomy. | |||||||||||||||
| No Effect | 1 Lowest | 2 Average | 3 Highest |
| Program Outcomes | Level of Contribution | |
| 1) | Physiotherapy defines the basic medical sciences concepts and principles related to physiotherapy and rehabilitation evaluation processes, basic elements and methodological application principles. | 2 |
| 2) | He/She lists clinical evaluation tools and methods by analyzing the collected information about evaluation in physiotherapy according to reasoning and problem solving processes. | 1 |
| 3) | Explain the indications, contraindications, side effects and intervention strategies of the physiotherapy approaches and the mechanisms used to cope with functional disability and possible intervention methods. Sorts the near and far term targets according to functional levels. | 1 |
| 4) | It is based on the physiotherapy information related to the general health of the service area. It defines the health and lifestyle profile, deficiencies, body structure and function, activity-participation level of the person and determines the evaluation and treatment priorities in this direction. | 2 |
| 5) | With the data obtained from physiotherapy assessments, it creates and implements an individual-oriented physiotherapy intervention plan in accordance with the diagnosis of physiotherapy by using information literacy, evidence-based clinical decision-making processes. | 2 |
| 6) | It applies to the service area the exercise program planned as well as consultancy in the protection and development of health outside the disease states. | 1 |
| 7) | Develops a scientific research proposal about physiotherapy and rehabilitation. | 1 |
| 8) | He leads the clinical practice in accordance with the quality standards in the process of establishment and management of the institutions / organizations / centers providing physiotherapy and rehabilitation services. | |
| 9) | As a physical therapist, he works with his colleagues and professionals from different disciplines. | 3 |
| 10) | Evaluates information sources with a critical approach by adapting to new conditions, learning new ideas, developing new ideas, and giving importance to quality. | 1 |
| 11) | By using professional information sources and physiotherapy techniques effectively, it reaches information, adopts positive attitude and behavior model and determines learning objectives. | 2 |
| 12) | Uses effective communication skills by respecting the confidentiality of service areas from a biopsychosocial point of view during physiotherapy evaluation and interventions. | 1 |
| 13) | It adopts the ethical, deontological and legal framework for the collection, recording and reporting of necessary data during the physiotherapy evaluation and interventions. | 1 |
| 14) | Observes the rights and responsibilities of the physicians in physiotherapy and rehabilitation practices and acts in accordance with the legislation and professional ethics rules in cooperation with the related disciplines. | 1 |
| 15) | Physiotherapist takes responsibility with the understanding of interdisciplinary cooperation while preserving its identity, consciousness and professional autonomy. | 1 |
| Semester Requirements | Number of Activities | Level of Contribution |
| Midterms | 1 | % 40 |
| Final | 1 | % 60 |
| total | % 100 | |
| PERCENTAGE OF SEMESTER WORK | % 40 | |
| PERCENTAGE OF FINAL WORK | % 60 | |
| total | % 100 | |
| Activities | Number of Activities | Workload |
| Course Hours | 16 | 32 |
| Study Hours Out of Class | 16 | 32 |
| Midterms | 1 | 1 |
| Final | 1 | 1 |
| Total Workload | 66 | |